Introduction：Basic information about CAS 7578-25-8|LACTO-N-FUCOPENTAOSE I, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | LACTO-N-FUCOPENTAOSE I |
|---|
| CAS Number | 7578-25-8 | Molecular Weight | 853.77100 |
|---|
| Density | / | Boiling Point | / |
|---|
| Molecular Formula | C32H55NO25 | Melting Point | / |
|---|
| MSDS | / | Flash Point | / |
|---|
Names
| Name | lnfp i |
|---|
| Synonym | More Synonyms |
|---|
LACTO-N-FUCOPENTAOSE I BiologicalActivity
| Description | Lacto-N-fucopentaose I (LNFPI) is a human milk oligosaccharide (HMO), possessing antiviral and antibacterial activity. Lacto-N-fucopentaose I can reduce capsid protein VP1 to block virus adsorption, promote CDK2 and reduce cyclin E to recover cell cycle S phase block. Lacto-N-fucopentaose I inhibits ROS production and apoptosis in virus-infected cells. Lacto-N-fucopentaose I can also regulate intestinal microbiota to affect immune system development[1]. |
|---|
| Related Catalog | Signaling Pathways >>Apoptosis >>ApoptosisResearch Areas >>InfectionResearch Areas >>Inflammation/ImmunologySignaling Pathways >>Cell Cycle/DNA Damage >>CDKSignaling Pathways >>Anti-infection >>Bacterial |
|---|
| Target | Human Endogenous Metabolite CDK2/cyclinE |
|---|
| In Vitro | Lacto-N-fucopentaose I (25-3200 μg/mL;48 h) exhibits certain cytotoxicity at 3200 μg/mL but no toxic reaction below 1600 μg/mL[1]. Lacto-N-fucopentaose I (25-1600 μg/mL; 14-18 h) can protect EV71-infected RD cells from death[1]. Lacto-N-fucopentaose I (100-400 μg/mL; 16 h) decreases markedly mRNA levels of VP1 and ROS production in EV71-infected RD cells at 400 μg/mL; leads to the recovery of EV71-induced S phase arrest in RD cells[1]. Lacto-N-fucopentaose I (100 and 200 μg/mL; 3 days) inhibits cell apoptosis in Caenorhabditis elegans; significantly decreases the levels of Egl-1, Ced-3 and Ced-4[1]. Lacto-N-fucopentaose I can reduce the abundance of Sphingobacterium, Stenotrophomonas and Achromobacter; can increase the abundance of Micromonospora, Vibrio, Acidibacter, Gaiella, Devosia, Steroidobacter, Variibacter, Dactylosporangium, RB41, Pir4_lineage, Pirellula, Haliangium, Roseiflexus, Pedomicrobium, and Bradyrhizobium. Cell Viability Assay[1] Cell Line: RD cells Concentration: 25, 50, 100, 200, 400, 800, 1600 and 3200 μg/mL Incubation Time: 48 h Result: Exhibited certain cytotoxicity at 3200 μg/mL but no toxic reaction below 1600 μg/mL. RT-PCR[1] Cell Line: RD cells (infected with EV71) Concentration: 100, 200 and 400 μg/mL Incubation Time: 16 h Result: Decreased markedly mRNA levels of VP1 only at 400 μg/mL. Apoptosis Analysis[1] Cell Line: RD cells (infected with EV71) Concentration: 100, 200 and 400 μg/mL Incubation Time: 16 h Result: Decreased the rate of cells in early apoptosis to 10.9% ± 1.26% at 400 μg/mL, while the untreated EV71 group was 27.7% ± 2.13%. Significantly inhibited the activity of caspase-3, caspase-8 and caspase-9. Recovered the decreased mRNA expression of PAPR, NF-κB and Bcl-2 and properly regulated Bad and Fas into their normal levels. Cell Cycle Analysis[1] Cell Line: RD cells (infected with EV71) Concentration: 100, 200 and 400 μg/mL Incubation Time: 12 h Result: Rescued EV71-induced S phase arrest, which promoted the transition of the G1 phase to the S phase. |
|---|
| References | [1]. Gao X, et al. Fucosylated oligosaccharide Lacto-N-fucopentaose I ameliorates enterovirus 71 infection by inhibiting apoptosis. Food Chem X. 2022 Feb 4;13:100244. |
|---|
Chemical & Physical Properties
| Molecular Formula | C32H55NO25 |
|---|
| Molecular Weight | 853.77100 |
|---|
| Exact Mass | 853.30600 |
|---|
| PSA | 423.46000 |
|---|
| Storage condition | 2-8℃ |
|---|
Safety Information
| Hazard Codes | Xi |
|---|
| Risk Phrases | 20/21/22-37/38-41 |
|---|
| Safety Phrases | 26-36/37/39 |
|---|
Synonyms
